Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Targeting α4β7 integrin reduces mucosal transmission of simian immunodeficiency virus and protects gut-associated lymphoid tissue from infection

Subjects

Abstract

α4β7 integrin–expressing CD4+ T cells preferentially traffic to gut-associated lymphoid tissue (GALT) and have a key role in HIV and simian immunodeficiency virus (SIV) pathogenesis. We show here that the administration of an anti-α4β7 monoclonal antibody just prior to and during acute infection protects rhesus macaques from transmission following repeated low-dose intravaginal challenges with SIVmac251. In treated animals that became infected, the GALT was significantly protected from infection and CD4+ T cell numbers were maintained in both the blood and the GALT. Thus, targeting α4β7 reduces mucosal transmission of SIV in macaques.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Kinetics of plasma viral load and tissue and organ specific pro-viral DNA loads.
Figure 2: Frequency of lymphocyte subsets from infected macaque peripheral blood mononuclear cells (PBMCs) and inhibition of MAdCAM or SIVmac251 gp120 by α4β7-mAb.

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  1. Brenchley, J.M. & Douek, D.C. Curr. Opin. HIV AIDS 3, 356–361 (2008).

    Article  Google Scholar 

  2. Mehandru, S. et al. J. Exp. Med. 200, 761–770 (2004).

    Article  CAS  Google Scholar 

  3. Veazey, R.S. et al. Science 280, 427–431 (1998).

    Article  CAS  Google Scholar 

  4. Bargatze, R.F., Jutila, M.A. & Butcher, E.C. Immunity 3, 99–108 (1995).

    Article  CAS  Google Scholar 

  5. Erle, D.J. et al. J. Immunol. 153, 517–528 (1994).

    CAS  PubMed  Google Scholar 

  6. Arthos, J. et al. Nat. Immunol. 9, 301–309 (2008).

    Article  CAS  Google Scholar 

  7. Nakamura, G.R., Fonseca, D.P., O'Rourke, S.M., Vollrath, A.L. & Berman, P.W. PLoS ONE 7, e39045 (2012).

    Article  CAS  Google Scholar 

  8. Nawaz, F. et al. PLoS Pathog. 7, e1001301 (2011).

    Article  CAS  Google Scholar 

  9. Pereira, L.E. et al. Cell. Immunol. 259, 165–176 (2009).

    Article  CAS  Google Scholar 

  10. Ansari, A.A. et al. J. Immunol. 186, 1044–1059 (2011).

    Article  CAS  Google Scholar 

  11. Kwa, S. et al. Blood 118, 2763–2773 (2011).

    Article  CAS  Google Scholar 

  12. Kelly, K.A. & Rank, R.G. Infect. Immun. 65, 5198–5208 (1997).

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Cicala, C. et al. Proc. Natl. Acad. Sci. USA 106, 20877–20882 (2009).

    Article  CAS  Google Scholar 

  14. Kader, M. et al. Mucosal Immunol. 2, 439–449 (2009).

    Article  CAS  Google Scholar 

  15. Martinelli, E. et al. J. Acquir. Immune Defic. Syndr. 64, 325–331 (2013).

    Article  CAS  Google Scholar 

  16. McKinnon, L.R. et al. J. Immunol. 187, 6032–6042 (2011).

    Article  CAS  Google Scholar 

  17. Feagan, B.G. et al. N. Engl. J. Med. 369, 699–710 (2013).

    Article  CAS  Google Scholar 

  18. Jovani, M. & Danese, S. Curr. Drug Targets 14, 1433–1443 (2013).

    Article  CAS  Google Scholar 

  19. Sandborn, W.J. et al. N. Engl. J. Med. 369, 711–721 (2013).

    Article  CAS  Google Scholar 

  20. Danese, S. et al. Ann. Intern. Med. 160, 704–711 (2014).

    Article  Google Scholar 

  21. Moreland, A.J. et al. BMC Genomics 12, 295 (2011).

    Article  CAS  Google Scholar 

  22. O'Leary, C.E. et al. Immunogenetics 61, 689–701 (2009).

    Article  CAS  Google Scholar 

  23. Lim, S.Y. et al. PLoS Pathog. 6, e1000738 (2010).

    Article  Google Scholar 

  24. Nguyen, D.C., Scinicariello, F. & Attanasio, R. Immunogenetics 63, 351–362 (2011).

    Article  CAS  Google Scholar 

  25. Butler, K. et al. AIDS Res. Hum. Retroviruses 29, 1091–1094 (2013).

    Article  CAS  Google Scholar 

  26. Subbarao, S. et al. J. Med. Primatol. 36, 238–243 (2007).

    Article  Google Scholar 

  27. Ansari, A.A. et al. J. Immunol. 186, 1044–1059 (2011).

    Article  CAS  Google Scholar 

  28. Hudgens, M.G. & Gilbert, P.B. Biometrics 65, 1223–1232 (2009).

    Article  Google Scholar 

  29. Regoes, R.R., Longini, I.M., Feinberg, M.B. & Staprans, S.I. PLoS Med. 2, e249 (2005).

    Article  Google Scholar 

  30. Letvin, N.L. et al. J. Virol. 81, 12368–12374 (2007).

    Article  CAS  Google Scholar 

  31. Promadej-Lanier, N. et al. J. Acquir. Immune Defic. Syndr. 53, 574–581 (2010).

    Article  CAS  Google Scholar 

  32. Veazey, R.S., Shattock, R.J., Klasse, P.J. & Moore, J.P. Curr. HIV Res. 10, 79–87 (2012).

    Article  CAS  Google Scholar 

  33. Spear, G., Rothaeulser, K., Fritts, L., Gillevet, P.M. & Miller, C.J. PLoS ONE 7, e52992 (2012).

    Article  CAS  Google Scholar 

  34. McKinnon, L.R. et al. J. Immunol. 187, 6032–6042 (2011).

    Article  CAS  Google Scholar 

  35. Pereira, L.E. et al. Cell. Immunol. 259, 165–176 (2009).

    Article  CAS  Google Scholar 

  36. Arthos, J. et al. Nat. Immunol. 9, 301–309 (2008).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by a grant from the NIH-NIAID AI-098628-01 (to A.A.A.), the NIAID NIH Intramural Research Program and OD 51POD1113 to the Yerkes National Primate Research Center. We are grateful to F. Connor-Stroud for help with the cytobrush studies and to the veterinary staff and animal caretakers of the Yerkes National Primate Center of Emory University, specially S. Ehnert and her team. The authors also acknowledge the assistance of M. Piatak for performing the ultrasensitive PCR analysis and R. Kaul and L.R. McKinnon for sharing with us their finding on cervical brush analyses in Africa and advising us on how to proceed in adapting their human findings to our nonhuman primates. Recombinant mAbs were produced by the Nonhuman Primate Reagent Resource (NIAID, NIH contract # HHSN272200900037C). The virus stock of SIVmac251 was obtained courtesy of N. Miller (NIAID, NIH). We apologize to all the authors whose publications we failed to cite. The findings in this report are those of the authors and do not necessarily reflect the views of the US Centers for Disease Control and Prevention.

Author information

Authors and Affiliations

Authors

Contributions

The day-to-day scheduling of the experiments were carried out under the laboratory supervision of A.E.M., technically performed by S.N.B., B.K., P.D., T.V. and D.L. The experiments described in Figure 2d–h were performed by F.N. and J.H. The overall planning and direction of the studies was carried out by A.A.A. C.C., F.V. and P.J.S. in regularly scheduled consultation with E.N.K., J.M.M. and T.G.P. D.H. provided the statistical planning of the studies and performed the statistical analyses of the data obtained. K.A.R. consulted and provided the large-scale preparation of the recombinant α4β7 monoclonal antibody and the normal rhesus IgG mAbs. M.B. and L.W. performed the major histocompatibility complex typing of the animals, and K.R. performed the Fc receptor typing of the animals. A.A.A. and T.G.P. prepared the draft of this manuscript with input from all the authors. A.S.F. provided helpful discussions and review and revision of the manuscript.

Corresponding author

Correspondence to Aftab A Ansari.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–5 and Supplementary Tables 1 and 2 (PDF 701 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Byrareddy, S., Kallam, B., Arthos, J. et al. Targeting α4β7 integrin reduces mucosal transmission of simian immunodeficiency virus and protects gut-associated lymphoid tissue from infection. Nat Med 20, 1397–1400 (2014). https://doi.org/10.1038/nm.3715

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.3715

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing